Health
In the wake of the devastating Marshall Fire, a team of chemists and engineers from CU 91Ҹ undertook a first-of-its-kind study to explore homes that survived the blaze. Their results reveal the potential health hazards that wildfires can leave behind in buildings.
Maciej Walczak, CU 91Ҹ associate professor of chemistry, won a $2 million NIH grant to investigate how certain sugars modify a brain protein associated with neurodegeneration.
New research shows that cancer cells can adapt in as little as one to two hours to new drugs called CDK2 inhibitors. The good news: Adding a second, widely available drug disables this workaround, squelching tumor growth.
An ancient, virus-like protein best known for its essential role in placental development may, when over-expressed, fuel ALS—aka Lou Gehrig's disease—and other neurodegenerative diseases, according to new research. The discovery opens the door to a new class of potential treatments.
A revolutionary technique for editing genomes, called CRISPR-Cas9, has already helped cure sickle cell disease in dozens of people. But it also raises ethical concerns, which a panel of preeminent scientists grappled with at an event on the CU 91Ҹ campus.
A study led by a CU 91Ҹ researcher finds that flavored tobacco products reduce the likelihood of cessation later, but researchers say more investigation is needed.
A new study led by Angela Bryan, a CU 91Ҹ professor and cancer survivor, is among the first to assess how cannabis bought over the counter at dispensaries—rather than government-supplied or synthetic varieties—impacts cancer symptoms or chemotherapy side effects.
The study of 46 million births across nearly three decades is among the first to provide population-level statistical evidence of “obstetric racism,” a term coined recently to describe a concerning pattern of maltreatment of non-white pregnant women, including a disregard for their birthing wishes.
Imagine carrying a UV device in your backpack and pulling it out to disinfect your bus seat or restaurant table. A new CU 91Ҹ study shows that using a technology called Far UV-C kills almost 100% of pathogens within a few seconds, without risk to human bystanders.
By inhibiting a protein that helps cancer cells repair themselves, scientists hope to develop new drugs that treat resistant tumors with fewer side effects.